Short answer · Medically reviewed summary · Last updated: 2023-07-13
Mikulicz Syndrome, also known as Mikulicz disease or Mikulicz-Radecki syndrome, is a rare autoimmune disorder characterized by the chronic inflammation of the salivary and lacrimal glands. It was first described by Austrian physician Johann von Mikulicz-Radecki in the late 19th century.
What is the prevalence of Mikulicz Syndrome?
Prevalence of Mikulicz Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Mikulicz Syndrome, also known as Mikulicz disease or Mikulicz-Radecki syndrome, is a rare autoimmune disorder characterized by the chronic inflammation of the salivary and lacrimal glands. It was first described by Austrian physician Johann von Mikulicz-Radecki in the late 19th century. The condition typically presents with bilateral swelling of the salivary and lacrimal glands, leading to dryness of the mouth and eyes.
Due to its rarity, the prevalence of Mikulicz Syndrome is not well-established. There is limited epidemiological data available on this specific syndrome. However, it is important to note that Mikulicz Syndrome can occur as a primary condition or as a manifestation of other underlying diseases, such as Sjögren's syndrome, lymphoma, or sarcoidosis.
As with many rare diseases, accurate prevalence rates are challenging to determine. The available literature suggests that Mikulicz Syndrome is a relatively uncommon condition. Further research and comprehensive studies are needed to establish a more precise prevalence estimate.
